Literature DB >> 12746980

Digital karyometry in pancreatic adenocarcinoma.

Vivian Pierri Bersch1, Vinicius Duval da Silva, Alessandro Bersch Osvaldt, Mário Sérgio Borges da Costa, Luiz Rohde, Diego Mossmann.   

Abstract

OBJECTIVE: To characterize nuclei from pancreatic adenocarcinoma and nonneoplastic pancreatic tissue by digital karyometry, demonstrating specific nuclear signatures for each of them. STUDY
DESIGN: Of cells from malignant and nonmalignant pancreatic tissue, 1,300 nuclei were assessed by digital karyometry from paraffin blocks stored at the Pathology Service of Hospital de Clinicas de Porto Alegre. A set of 40 features descriptive of the spatial and statistical distribution of nuclear chromatin was computed for each nucleus. Signatures were created for both types of tissue, and a distance metric from "normal" was defined and calculated for them.
RESULTS: There were significant differences in 11 features between the 2 groups, allowing the creation of digital signatures.
CONCLUSION: Nuclear chromatin texture signature can offer a specific digital characterization for both pancreatic adenocarcinoma and nonmalignant pancreatic tissue. Several isolated nuclear features serve as markers for the diagnosis of pancreatic adenocarcinoma. The present karyometric study of normal and malignant pancreatic tissue may be of use as a continuing tool to early diagnosis of pancreatic adenocarcinoma as it can be applied to cytologic specimens, also. In the future, studies using this technique should assess the chemopreventive potential of different agents as well as prognosis and treatment options for pancreatic adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746980

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  1 in total

1.  Evaluating IPMN and pancreatic carcinoma utilizing quantitative histopathology.

Authors:  Evan S Glazer; Hao Helen Zhang; Kimberly A Hill; Charmi Patel; Stephanie T Kha; Michael L Yozwiak; Hubert Bartels; Nellie N Nafissi; Joseph C Watkins; David S Alberts; Robert S Krouse
Journal:  Cancer Med       Date:  2016-09-26       Impact factor: 4.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.